EMA AND FDA COMBINE EFFORTS ON PHARMACOVIGILANCE
March 1st, 2014
THE USA’s Food & Drug Administration (FDA) and the European Medicines Agency (EMA) are to combine efforts on pharmacovigilance, establishing a regular liaison system. An FDA note said discussions on shared pharmacovigilance issues will now take place between the agencies each month by teleconference. It said: “This increased degree of interaction will allow the agencies to work swiftly in the area of the safety of medicines and to coordinate communication activities.” Physical meetings between experts will also take place, with EMA calling the new ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.